AAAAAA

   
Results: 1-10 |
Results: 10
INCOMPLETE EMBRYONIC LETHALITY AND FATAL NEONATAL HEMORRHAGE CAUSED BY PROTHROMBIN DEFICIENCY IN MICE
Authors: XUE JC WU QY WESTFIELD LA TULEY EA LU DS ZHANG Q SHIM K ZHENG XL SADLER JE
Citation: Jc. Xue et al., INCOMPLETE EMBRYONIC LETHALITY AND FATAL NEONATAL HEMORRHAGE CAUSED BY PROTHROMBIN DEFICIENCY IN MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 95(13), 1998, pp. 7603-7607
PARTIAL EMBRYONIC LETHALITY INDUCED BY TARGETED INACTIVATION OF THE PROTHROMBIN GENE IN MICE
Authors: XUE J WU Q WESTFIELD LA TULEY EA LU D ZHANG Q ZHENG X SADLER JE
Citation: J. Xue et al., PARTIAL EMBRYONIC LETHALITY INDUCED BY TARGETED INACTIVATION OF THE PROTHROMBIN GENE IN MICE, Thrombosis and haemostasis, 1997, pp. 707-707
DOMINANT TYPE-1 VON-WILLEBRAND DISEASE CAUSED BY MUTATED CYSTEINE RESIDUES IN THE D3 DOMAIN OF VON-WILLEBRAND-FACTOR
Authors: EIKENBOOM JCJ MATSUSHITA T REITSMA PH TULEY EA CASTAMAN G BRIET E SADLER JE
Citation: Jcj. Eikenboom et al., DOMINANT TYPE-1 VON-WILLEBRAND DISEASE CAUSED BY MUTATED CYSTEINE RESIDUES IN THE D3 DOMAIN OF VON-WILLEBRAND-FACTOR, Blood, 88(7), 1996, pp. 2433-2441
A GENETICALLY-ENGINEERED MOUSE MODEL OF TOTAL PROTHROMBIN DEFICIENCY
Authors: XUE J WU Q WESTFIELD LA TULEY EA LU D ZHANG Q SADLER JE
Citation: J. Xue et al., A GENETICALLY-ENGINEERED MOUSE MODEL OF TOTAL PROTHROMBIN DEFICIENCY, Blood, 88(10), 1996, pp. 1862-1862
MOLECULAR MECHANISM AND CLASSIFICATION OF VON-WILLEBRAND DISEASE
Authors: SADLER JE MATSUSHITA T DONG ZY TULEY EA WESTFIELD LA
Citation: Je. Sadler et al., MOLECULAR MECHANISM AND CLASSIFICATION OF VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 74(1), 1995, pp. 161-166
A NEW FAMILY WITH TYPE 2N (NORMANDY) VON-WILLEBRAND DISEASE WITH THE ARG53-]TRP MUTATION
Authors: DEBOSCH NB TULEY EA TORRES A SAEZ A SADLER JE
Citation: Nb. Debosch et al., A NEW FAMILY WITH TYPE 2N (NORMANDY) VON-WILLEBRAND DISEASE WITH THE ARG53-]TRP MUTATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1167-1167
DOMINANT TYPE-1 VON-WILLEBRAND DISEASE-ASSOCIATED WITH MUTATED CYSTEINE RESIDUES IN THE D3-DOMAIN OF VON-WILLEBRAND-FACTOR
Authors: EIKENBOOM JCJ REITSMA PH CASTAMAN G TULEY EA BRIET E SADLER JE
Citation: Jcj. Eikenboom et al., DOMINANT TYPE-1 VON-WILLEBRAND DISEASE-ASSOCIATED WITH MUTATED CYSTEINE RESIDUES IN THE D3-DOMAIN OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 73(6), 1995, pp. 1170-1170
CHARACTERIZATION OF PARTIAL GENE DELETIONS IN TYPE-III VON-WILLEBRANDDISEASE WITH ALLOANTIBODY INHIBITORS
Authors: MANCUSO DJ TULEY EA CASTILLO R DEBOSCH N MANNUCCI PM SADLER JE
Citation: Dj. Mancuso et al., CHARACTERIZATION OF PARTIAL GENE DELETIONS IN TYPE-III VON-WILLEBRANDDISEASE WITH ALLOANTIBODY INHIBITORS, Thrombosis and haemostasis, 72(2), 1994, pp. 180-185
DISULFIDE BONDS REQUIRED TO ASSEMBLE FUNCTIONAL VON-WILLEBRAND-FACTORMULTIMERS
Authors: DONG ZG THOMA RS CRIMMINS DL MCCOURT DW TULEY EA SADLER JE
Citation: Zg. Dong et al., DISULFIDE BONDS REQUIRED TO ASSEMBLE FUNCTIONAL VON-WILLEBRAND-FACTORMULTIMERS, The Journal of biological chemistry, 269(9), 1994, pp. 6753-6758
TYPE-IIB MUTATION HIS-505 -] ASP IMPLICATES A NEW SEGMENT IN THE CONTROL OF VON-WILLEBRAND-FACTOR BINDING TO PLATELET GLYCOPROTEIN-IB
Authors: RABINOWITZ I RANDI AM SHINDLER KS TULEY EA RUSTAGI PK SADLER JE
Citation: I. Rabinowitz et al., TYPE-IIB MUTATION HIS-505 -] ASP IMPLICATES A NEW SEGMENT IN THE CONTROL OF VON-WILLEBRAND-FACTOR BINDING TO PLATELET GLYCOPROTEIN-IB, The Journal of biological chemistry, 268(27), 1993, pp. 20497-20501
Risultati: 1-10 |